R&D CENTER

IVL Formulation Center
(IFC)Certification of corporate subsidiary lab

At IFC, we study formulations for long-lasting
injectables based on our unique platform technology,
IVL-DrugFluidic®. The research of drug formulations of each pipeline
allowed us to achieve the innovations of stability and
quality of drug formulations through the optimization
of precisely controlled drug-release, which cannot be
easily implemented in its original formulation and
manufacturing technologies. Through this, IMD (Unique-in-Class) and New Drugs
(Drug-Rediscovery) are being researched. There are
currently 20 registered and 60 pending patents in
total.

R&D CENTER

IVL Platform Center
(IPC)Certification of corporate subsidiary lab

Platform technology refers to a technology that can be
applied to any types of drugs, of which various drugs
can be manufactured using one platform technology. IPC is the Platform Research Center of Inventage
Labs. IPC developes platform technologies for
delivering sustained-release and genetic drugs and
performing scale-up research to enable mass
production. The platform technology is consistently applied
through the development stages from initial research
at IFC to mass production, with the advantage of
being able to maintain high quality. Through IPC's platform and scale-up research, our
sterile GMP system built in-house solves the existing
difficulties that other pharmaceutical companies may
still have, such as maintenance of high quality and
scale-up.

MANUFACTURING CENTER

IVL Manufacturing Center
(IMC)

IMC is a GMP-compliant center for drug mass
production, where facilities, manufacturing, and
quality control are managed according to the latest
GMP standards. IMC has a GMP plant for manufacturing sustained-
release aseptic injections based on IVL-DrugFluidic®
technology. IMC has also acquired KVGMP, a Korean
GMP for veterinary medicines, and a grade 4 medical
device (injection) GMP certification. After going through Lab Scale and Pilot Scale for the
products developed in the research phase, IMC
produces them at GMP level, at mass production
scale.